Literature DB >> 2932618

Normal excretion of quinolinic acid in Huntington's disease.

M P Heyes, E S Garnett, R R Brown.   

Abstract

We measured the excretion of the endogenous neurotoxin quinolinic acid in 14 patients with Huntington's disease and in 11 age matched control subjects. Huntingtonian patients excreted less quinolinic acid, than controls. When normalised to urea or creatinine output quinolinic acid excretion was normal. We conclude that Huntington's disease is not associated with a generalised disturbance of quinolinic acid metabolism, however, a local hyperproduction of quinolinic acid cannot be excluded from our results.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932618     DOI: 10.1016/0024-3205(85)90223-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims.

Authors:  R Schwarcz; E Okuno; R J White; E D Bird; W O Whetsell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Brain quinolinic acid in Alzheimer's dementia.

Authors:  E Sofic; J Halket; A Przyborowska; P Riederer; H Beckmann; M Sandler; K Jellinger
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

Review 3.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.